NASDAQ NMS - GLOBAL MARKET · ARCT
-3.06% · -$0.3900 · Vol 146.2K
Live · updated 11:55:49 ET
Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Holdings Inc

Biotechnology
$12.38
Card
Relationship Map

Follow $ARCT

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $ARCT by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
ARCT
Arcturus Therapeutics Holdings Inc
Wed Oct 7 · last completed session · daily score · 18h old
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

69/ 100
Veridion Score
Upper range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Wed Oct 7 · last completed session · daily score · 18h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ARCT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ARCT catalysts
About Arcturus Therapeutics Holdings Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2013
Employees
111
Country
US

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$12.60
Day high
$12.60
Day low
$12.03
Previous close
$12.77
52W high
$23.16
-46.57% from high
52W low
$5.53
39% of range
Market cap
$362.8M
EPS
$-3.3143
Beta
1.38
Shares out
28.4M
Volume
146.2K
0.15× rel vol
Avg volume
969.1K
VWAP
$12.40
Price history computed in-house
1W
-6.32%
1M
-20.83%
3M
+77.55%
1Y
-41.63%
YTD
+101.88%
SMA 50 $12.25 · above
SMA 200 $8.60 · above
52W position 39%

ARCT overview

Veridion Score
69
Registered · 2026-10-07
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ARCT.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ARCT Form 4 filings
Public disclosures

Congress activity in ARCT

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

ARCT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ARCT in this window.
Lobbying spend

ARCT lobbying filings, year to date.

Registered lobbying filings matched to Arcturus Therapeutics Holdings Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ARCT in this window.
Loading news for ARCT
Analyst ratings
Sovereign unlock shows live analyst consensus for ARCT.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.